Breast cancer cells interact with osteoblasts to support osteoclast formation

Endocrinology

Volumn 140, Issue 10, 1999, Pages 4451-4458

  Thomas, R J ^a   Guise, T A ^a   Yin, J J ^a   Elliott, J ^a   Horwood, N J ^a   Martin, T J ^a   Gillespie, M T ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CELL INTERACTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033305222     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.10.7037     Document Type: Article

References (35)

1. Mechanisms of bone metastasis
2. Parathyroid hormone-related protein and bone metastases
3. Cancer and bone
4. Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers
5. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma
6. Cytokines and growth factors in the regulation of bone remodeling
7. Role of cytokines in bone resorption
8. Reduction in new metastases in breast cancer with adjuvant clodronate treatment
9. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group
10. Induction of calcitonin receptors by 1α, 25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells
11. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
12. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
13. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
14. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts
15. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
16. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor
17. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
18. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
19. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by Which OPG/OCIF inhibits osteoclastogenesis in vitro
20. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
21. Interleukins in the control of osteoclast differentiation
22. Osteoblastic cells are involveci in osteoclast formation
23. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells
24. Resorption of bone by isolated rabbit osteoclasts
25. Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tumours
26. A murine model of experimental metastasis to bone and bone marrow
27. Modified immunoradiometric assay of parathyroid hormone-related protein: Clinical application in the differential diagnosis of hypercalcemia
28. Interleukin-18 (interferon-γ-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation
29. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis
30. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells
31. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
32. Transforming growth factor β stimulation of parathyroid hormone- related protein (PTHrP): A paracrine regulator?
33. Effect of transforming growth factor-beta1 on parathyroid hormone-related protein secretion and mRNA expression by normal human keratinocytes in vitro
34. Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells